Patents Assigned to Johnson & Johnson Vision Care, Inc.
-
Patent number: 11971518Abstract: Disclosed herein are compositions and methods comprising a composition for light filtering. An example composition comprises a plurality of metal nanoparticles, at least a portion of the plurality of metal nanoparticles having an anisotropic shape; and a stabilizing mechanism disposed to selectively couple with at least a portion of the plurality of metal nanoparticles, wherein the composition exhibits a peak light filtering value in the range of about 600 nm to about 850 nm.Type: GrantFiled: April 28, 2022Date of Patent: April 30, 2024Assignee: Johnson & Johnson Vision Care, Inc.Inventors: Frank Gu, Aaron Joshua Clasky, Paul Chen
-
Patent number: 11970431Abstract: Described are polymerizable high energy light absorbing compounds of formula I: Wherein Y, Pg, R2, R3, R4, R5, and R6 are as described herein. The compounds absorb various wavelengths of ultraviolet and/or high energy visible light and are suitable for incorporation in various products, such as biomedical devices and ophthalmic devices.Type: GrantFiled: May 27, 2021Date of Patent: April 30, 2024Assignee: Johnson & Johnson Vision Care, Inc.Inventors: Ghulam Maharvi, Shivkumar Mahadevan, Stephen C. Arnold, Patricia Martin, Leilani K. Sonoda, Dola Sinha
-
Patent number: 11958824Abstract: Described are visible light absorbing compounds. The compounds have a visible light absorption maximum between 430 and 480 nm and a full width half maximum (FWHM) at the visible light absorption maximum of at least 35 nm and up to 100 nanometers, wherein the compounds are photostable. The compounds substantially mimic the visible light absorbance properties of macular pigment while remaining photostable. The compounds may be used in a variety of articles, including ophthalmic devices.Type: GrantFiled: June 11, 2020Date of Patent: April 16, 2024Assignee: Johnson & Johnson Vision Care, Inc.Inventor: Shivkumar Mahadevan
-
Patent number: 11953651Abstract: This invention relates to comfortable ophthalmic devices and methods of producing such devices.Type: GrantFiled: August 24, 2021Date of Patent: April 9, 2024Assignee: Johnson & Johnson Vision Care, Inc.Inventors: Kevin P. McCabe, Robert B. Steffen, Hélène Aguilar, W. Anthony Martin, Susan W. Neadle, Ann-Marie Wong Meyers, Douglas G. Vanderlaan, Dominic P. Gourd, Kristy L. Canavan, Gregory A. Hill
-
Patent number: 11945180Abstract: The present invention relates to a method of manufacturing a contact lens including the steps of: (i) adding reactive components to a mold, wherein the reactive components comprise (a) at least one hydroxy-containing silicone component having a weight average molecular weight from about 200 to about 15,000 g/mole and (b) at least one mono-ether terminated, mono-methacrylate terminated polyethylene glycol having a weight average molecular weight from about 200 to about 10,000 g/mole; (ii) curing the reactive components within the mold to form the contact lens; and (iii) removing the contact lens from said mold.Type: GrantFiled: October 1, 2020Date of Patent: April 2, 2024Assignee: Johnson & Johnson Vision Care, Inc.Inventors: Azaam Alli, Shivkumar Mahadevan
-
Patent number: 11947193Abstract: A storage container for contact lenses has a well for receiving a contact lens and a storage liquid and a floor. A support structure of the storage container holds the contact lens in a defined location above the floor of the well, the defined location having a lens depression area that in use permits depression of the contact lens under finger pressure, where the support structure supports a concave surface of a contact lens and acts as a fulcrum wherein the contact lens pivots about the fulcrum such a contact surface area of the contact lens deforms when pressure is applied to a portion of the contact lens in the depression area.Type: GrantFiled: May 12, 2021Date of Patent: April 2, 2024Assignee: Johnson & Johnson Vision Care, Inc.Inventors: Anthony John Greenwood, Guy St John Tristram Smith
-
Amide-functionalized polymerization initiators and their use in the manufacture of ophthalmic lenses
Patent number: 11912800Abstract: Provided are compounds that may function as functionalized polymerization initiators, for instance in the manufacture of ophthalmic lenses, and to methods of such manufacture. The compounds are of formula I: wherein R1, R2, R3, R4, R5, T, p, q, and n are as defined herein.Type: GrantFiled: August 22, 2022Date of Patent: February 27, 2024Assignee: Johnson & Johnson Vision Care, Inc.Inventors: Michael F. Widman, Ghulam Maharvi, Shivkumar Mahadevan, Azaam Alli, Alexander Guzman, Xin Wei, Minghan Chen -
Patent number: 11891526Abstract: Provided are ink compositions for making cosmetic contact lenses, as well as cosmetic contact lenses and methods for their preparation and use. The ink composition comprises: (a) a colorant; and (b) a nonreactive hydrophilic polymer.Type: GrantFiled: August 7, 2020Date of Patent: February 6, 2024Assignee: Johnson & Johnson Vision Care, Inc.Inventors: Jaqunda Patton, Yong Zhang, Alexander Guzman, Ghulam Maharvi
-
Patent number: 11885706Abstract: A method of determining the transmittance of a contact lens (200) includes the steps of obtaining a measurement of a first intensity of electromagnetic radiation reflected by ocular surface (100) with an intensity measuring device (400), positioning the contact lens (200) in direct contact with the ocular surface (100), obtaining a measurement of a second intensity of electromagnetic radiation transmitted through the contact lens (200) that is reflected a region (110) of the ocular surface (100) that is covered by the contact lens (200) with the intensity measuring device (400); and calculating the transmittance using the measurements of the first intensity and the second intensity.Type: GrantFiled: May 2, 2022Date of Patent: January 30, 2024Assignees: Transitions Optical, Ltd., Johnson & Johnson Vision Care, Inc.Inventors: Forrest R. Blackburn, Joshua Hazle, Patricia Martin
-
Patent number: 11874434Abstract: Various non-limiting embodiments of the present disclosure relate to ophthalmic devices comprising photochromic materials comprising a reactive substituent. For example, the present disclosure contemplates ophthalmic devices comprising photochromic materials, such as photochromic naphthopyrans and indeno-fused naphthopyrans having a reactive substituent comprising a reactive moiety linked to the photochromic naphthopyran by one or more linking groups. In certain non-limiting embodiments, the reactive moiety comprises a polymerizable moiety. In other non-limiting embodiments, the reactive moiety comprises a nucleophilic moiety. Other non-limiting embodiments of the present disclosure relate to methods of making the photochromic ophthalmic device, wherein the photochromic ophthalmic devices comprise the photochromic naphthopyrans described herein.Type: GrantFiled: January 18, 2022Date of Patent: January 16, 2024Assignee: Johnson & Johnson Vision Care, Inc.Inventors: Wenjing Xiao, Barry Van Gemert, Shivkumar Mahadevan, Frank Molock
-
Patent number: 11861823Abstract: Disclosed herein are methods for quantifying contact lens deposition. An example method may comprise disposing a contact lens sample in a fluid well. The example method may comprise disposing a volume of tear fluid in the well with the contact lens sample. The example method may comprise capturing pre-rinse images of the contact lens sample. The example method may comprise rinsing the contact lens sample. The example method may comprise capturing post-rinse images of the contact lens after the rinsing. The example method may comprise determining, using one or more of the tear images or the post-rinse images, a deposition metric. The example method may comprise outputting the deposition metric.Type: GrantFiled: April 27, 2021Date of Patent: January 2, 2024Assignee: Johnson & Johnson Vision Care, Inc.Inventors: Zhenyu Li, Bailin Liang
-
Patent number: 11853013Abstract: Described are systems and methods which can be used to indicate the period of time elapsed since the occurrence of a triggering event. More particularly, this application relates to systems and methods which can be used to visually indicate the time period elapsed since an article has been removed from its packaging. The system can include an indicator disposed on or within the article and a trigger disposed within the receptacle and in contact with the indicator. The article may be enclosed within a sealable receptacle of the package. The indicator is responsive to a change in a concentration of the trigger in contact with the indicator.Type: GrantFiled: June 15, 2020Date of Patent: December 26, 2023Assignee: Johnson & Johnson Vision Care, Inc.Inventors: Frank Gu, Paul Chen
-
Patent number: 11834547Abstract: Provided are ophthalmic devices comprised of a reaction product of a composition comprising: (i) a crosslinked substrate network containing covalently bound activatable free radical initiators; and (ii) a grafting composition containing one or more ethylenically unsaturated compounds. Also provided are processes for making ophthalmic devices.Type: GrantFiled: February 25, 2021Date of Patent: December 5, 2023Assignee: Johnson & Johnson Vision Care, Inc.Inventors: Brian Aitken, Charles Scales, Scott Joslin, Yong Zhang, Dola Sinha, Shivkumar Mahadevan, Patricia Martin, Fang Lu, Donnie Duis, Stephen C. Arnold
-
Patent number: 11827755Abstract: Described is a silicone hydrogel contact lens having non-uniform morphology. The contact lens may be made from a reactive mixture comprising: a silicone-containing component; a hydrophilic component; a non-reactive polymeric internal wetting agent; and a polymerization initiator, the contact lens having an oxygen permeability of at least about 60 barrers, and wherein the molar ratio in the lens of the polymeric non-reactive internal wetting agent to silicone, without a surface treatment, is greater in the lens's surface than in its bulk.Type: GrantFiled: December 13, 2022Date of Patent: November 28, 2023Assignee: Johnson & Johnson Vision Care, Inc.Inventors: Azaam Alli, Donald E. Riederer, Alexander Guzman, Bernardo Santa Maria
-
Patent number: 11828913Abstract: Described are silicone hydrogels that are more biocompatible than current ocular materials. The silicone hydrogels are formed from a reactive monomer mixture comprising: a mixture of hydroxyl substituted silicone containing components, at least one polyamide; and at least one hydrophilic monomer. The silicone hydrogels also display a desirable balance of properties, including clarity, oxygen permeability, wettability and desirable protein uptake.Type: GrantFiled: November 19, 2020Date of Patent: November 28, 2023Assignee: Johnson & Johnson Vision Care, Inc.Inventors: Azaam Alli, Alexander Guzman
-
Patent number: 11829008Abstract: A molded contact lens comprising a stiffer optic zone relative to the peripheral zone of the contact lens provides an optical element for correcting astigmatism without the need for or substantially minimizing the need for the correction of rotational misalignment. The higher elastic modulus optic zone vaults over the cornea thereby allowing a tear lens to form. The tear lens follows or assumes the shape of the back surface of the contact lens. The combination of the tear lens and the optical zone provide an optical element for correction of refractive error.Type: GrantFiled: October 19, 2021Date of Patent: November 28, 2023Assignee: Johnson & Johnson Vision Care, Inc.Inventors: Azaam Alli, Dola Sinha
-
Patent number: 11822153Abstract: Described herein are systems and/or methods for forming an ophthalmic lens. An example method may comprise a step of determining a power profile based on a power profile function defined by a base optical power, an amount of spherical aberration at a radial distance from a geometric center of the lens, and a bump function. The example method may comprise a step of adjusting the power profile based at least on minimizing a shape metric of a through-focus curve.Type: GrantFiled: September 28, 2020Date of Patent: November 21, 2023Assignee: Johnson & Johnson Vision Care, Inc.Inventors: Xin Wei, Philippe F Jubin, Derek Nankivil, Minghan Chen, Gregory Williby
-
Patent number: 11820850Abstract: Provided are polymer compositions made by a process comprising: (a) providing a first reactive composition containing: (i) a polymerization initiator that is capable, upon a first activation, of forming two or more free radical groups, at least one of which is further activatable by subsequent activation; (ii) one or more ethylenically unsaturated compounds; and (iii) a crosslinker; (b) subjecting the first reactive composition to a first activation step such that the first reactive composition polymerizes therein to form a crosslinked substrate network containing a covalently bound activatable free radical initiator, (c) combining the crosslinked substrate network with a second reactive composition containing one or more ethylenically unsaturated compounds; and (d) activating the covalently bound activatable free radical initiator of the crosslinked substrate network such that the second reactive composition polymerizes therein with the crosslinked substrate network to form a grafted polymeric network and aType: GrantFiled: April 28, 2021Date of Patent: November 21, 2023Assignee: Johnson & Johnson Vision Care, Inc.Inventors: Brian Aitken, Charles Scales, Scott Joslin, Yong Zhang, Dola Sinha, Shivkumar Mahadevan, Patricia Martin, Fang Lu, Donnie Duis, Stephen C. Arnold
-
Patent number: 11820899Abstract: Described are polymerizable high energy light absorbing compounds. The compounds absorb various wavelengths of ultraviolet and/or high energy visible light and are suitable for incorporation in various products, such as biomedical devices and ophthalmic devices.Type: GrantFiled: December 3, 2020Date of Patent: November 21, 2023Assignee: Johnson & Johnson Vision Care, Inc.Inventors: Shivkumar Mahadevan, Dawn D. Wright
-
Patent number: 11789292Abstract: The present disclosure relates to ophthalmic devices such as ophthalmic lenses. An ophthalmic device may comprise an ophthalmic lens for at least one of slowing, retarding or preventing myopia progression. The ophthalmic lens may comprise a center zone with a negative power for myopic vision correction; and at least one treatment zone surrounding the center zone, the at least one treatment zone having a power profile comprising an ADD power, the at least one treatment zone having a surface shape comprising a portion of a generally toroidal shape, wherein the at least one treatment zone is arranged as to form a continuous surface with the center zone.Type: GrantFiled: March 9, 2021Date of Patent: October 17, 2023Assignee: Johnson & Johnson Vision Care, Inc.Inventors: Noel A. Brennan, Xu Cheng, Jaclyn V. Hernandez, Michael J. Collins, Brett A. Davis, Fan Yi, Derek Dean Nankivil